… consequences? Here’s what CEOs at some of the … similar to ours.” Joaquin Duato CEO, Johnson & Johnson … Pfizer, AstraZeneca, Amgen and EMD Serono — that have agreed to sell … cost.” Leonard Schleifer CEO, Regeneron Regeneron CEO Leonard Schleifer, along …

… that Boston-based drugmaker EMD Serono will lower the price … cycles to get pregnant. EMD Serono’s medications, which also … expedite approval of an EMD Serono fertility drug used in … fertility cycle,” Roger Shedlin, CEO of fertility benefits company WIN …

… Along with the agreement, Serono announced its decision to … of the executive board and CEO of Merck KGaA, Darmstadt … from complex fertility complications, Serono announced its plan to … Ketamine Augmentin XR EMD Serono Announces Unprecedented Agreement with …

… and research investments. EMD Serono already has a strong … with future fertility manufacturing,” CEO of Merck KGaA, Darmstadt, … 16. Other than EMD Serono’s Pergoveris for infertility,  … in fertility therapeutics.” EMD Serono joins AstraZeneca and Pfizer …

… women struggling to conceive. EMD Serono agreed to provide direct-to … well as all of EMD Serono’s fertility medications through … access to IVF. EMD Serono has also reached an agreement … Merck executive board chair and CEO Belén Garijo stated: “We have …

… that Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics, will … sciences, including biotech and pharma CEOs, heads of research and development … Fernandez Alcalde (President, EMD Serono), Tarek Rabah (CEO, Otsuka North America), Levi …

… has announced a new chief executive to scale the company after … Dr. Bharat Tewarie as CEO, succeeding Justin Chen Li, … companies such as UCB, EMD Serono, Roche and Boehringer Ingelheim. … Tewarie had experience being CEO of other startups including Amsterdam …

… Miguel Fernández Alcalde, President, EMD Serono Christophe Arbet-Engels, MD, PhD … X4 Pharmaceuticals Catherine Owen Adams, Chief Executive Officer, Acadia Pharmaceuticals Pamela Gavin … -breakthrough-summit-to-spotlight-ceos-investors-and-regulatory-leaders- …

… posting letters addressed to the CEOs of 17 major pharmaceutical companies … Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead, GSK, Johnson … . Trump’s strategy puts industry CEOs on notice in a way …

The letters laid out specific demands, including matching the lowest global prices for Medicaid patients and ending preferential pricing abroad, while warning that failure to comply would trigger federal action. Retail buzz around major pharmaceutical …